Assessment of cyclosporine therapeutic monitoring with C 2 concentrations in stable renal allograft recipients

By Diaz J.M.   Sainz Z.   Guirado L.L.   Montanes R.   Picazo M.   Garcia-Camin R.   Alcaraz A.   Sola R.  

Transplantation Proceedings, Vol. 35, Iss. 5, 2003-08 ,pp. : 1783-1784

Elsevier

Access to resources Recommend Favorite

Cyclosporine absorption profiling and therapeutic drug monitoring using c 2 blood levels in stable renal allograft recipients

By Einecke G.   Mai I.   Diekmann F.   Fritsche L.   Neumayer H.-H.   Budde K.  

Transplantation Proceedings, Vol. 34, Iss. 5, 2002-08 ,pp. : 1738-1739

Elsevier

Access to resources Recommend Favorite

Feasibility of changing therapeutic cyclosporine monitoring from C 0 to C 2 in stable renal recipients: narrower coefficient of variation with C 2 monitoring

By Chueh S.-C.   Liao C.-H.   Chang C.-J.   Lai M.-K.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3100-3101

Elsevier

Access to resources Recommend Favorite

Pharmacodynamic monitoring of lymphocyte proliferation and TGF- 1 expression at cyclosporine a (CyA) trough levels (C 0 ) and 2 hours after intake (C 2 ) of CyA in human renal allograft recipients

By Bohler T.   Budde K.   Schneider M.   Eliazyfer S.   Dell K.   Einecke G.   Diekmann F.   Fritsche L.   Mai I.   Neumayer H.H.   Waiser J.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3148-3150

Elsevier

Access to resources Recommend Favorite

Neoral drug monitoring in stable kidney allotransplant recipients: C 0 versus C 2

By Lukaschek J.   Hofmann J.   Aerne D.   Ambuhl P.   Kistler T.   Knoflach A.   Pei P.   Binswanger U.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3104-3105

Elsevier

Access to resources Recommend Favorite